menu search

HOLX / Hologic, Inc. (HOLX) CEO Steve MacMillan on Q2 2022 Results - Earnings Call Transcript

Hologic, Inc. (HOLX) CEO Steve MacMillan on Q2 2022 Results - Earnings Call Transcript
Hologic, Inc. (NASDAQ:HOLX ) Q2 2022 Earnings Conference Call April 27, 2022 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Steve MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research Vijay Kumar - Evercore ISI Patrick Donnelly - Citi Puneet Souda - SVB Securities Tejas Savant - Morgan Stanley Casey Woodring - JPMorgan Derik de Bruin - Bank of America Ryan Zimmerman - BTIG Operator Good afternoon and welcome to the Hologic 2Q ‘22 Earnings Conference Call. My name is Lauren and I am your operator for today's call. Read More
Posted: Apr 27 2022, 23:23
Author Name: Seeking Alpha
Views: 102413

HOLX News  

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

By Zacks Investment Research
November 1, 2023

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. more_horizontal

Here's Why Hologic (HOLX) Fell More Than Broader Market

By Zacks Investment Research
October 23, 2023

Here's Why Hologic (HOLX) Fell More Than Broader Market

In the most recent trading session, Hologic (HOLX) closed at $67.56, indicating a -0.37% shift from the previous trading day. more_horizontal

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

By Zacks Investment Research
October 20, 2023

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the s more_horizontal

Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to Note

By Zacks Investment Research
October 16, 2023

Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to Note

In the latest trading session, Hologic (HOLX) closed at $69.22, marking a +0.35% move from the previous day. more_horizontal

Hologic (HOLX) to Elevate OB-GYN Training With New Partnerships

By Zacks Investment Research
October 12, 2023

Hologic (HOLX) to Elevate OB-GYN Training With New Partnerships

Hologic's (HOLX) collaboration with AAGL and Inovus Medical is likely to optimize OB-GYN training for minimally invasive surgeries. more_horizontal

Hologic (HOLX) Rises Yet Lags Behind Market: Some Facts Worth Knowing

By Zacks Investment Research
October 9, 2023

Hologic (HOLX) Rises Yet Lags Behind Market: Some Facts Worth Knowing

The latest trading day saw Hologic (HOLX) settling at $70.25, representing a +0.59% change from its previous close. more_horizontal

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

By Zacks Investment Research
October 9, 2023

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects more_horizontal

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

By Zacks Investment Research
September 27, 2023

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. more_horizontal


Search within

Pages Search Results: